Using nanoBRET and CRISPR/Cas9 to monitor proximity to a genome-edited protein in real-time

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  White, Carl W ^a,b   Vanyai, Hannah K ^a,b   See, Heng B ^a,b   Johnstone, Elizabeth K M ^a,b   Pfleger, Kevin D G ^a,b,c  

^a PATHWEST LABORATORY MEDICINE   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c Dimerix Bioscience Limited   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ARRESTIN; LIGAND; LUCIFERASE; NANOPARTICLE; PROTEIN; PROTEIN BINDING;

CHEMISTRY; CRISPR CAS SYSTEM; ENERGY TRANSFER; GENE EDITING; GENETICS; HUMAN; SIGNAL TRANSDUCTION;

BETA-ARRESTINS; CRISPR-CAS SYSTEMS; ENERGY TRANSFER; GENE EDITING; HUMANS; LIGANDS; LUCIFERASES; NANOPARTICLES; PROTEIN BINDING; PROTEINS; SIGNAL TRANSDUCTION;

EID: 85020633916     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-03486-2     Document Type: Article

References (69)

1. Smith, J. S. & Rajagopal, S. The beta-Arrestins: Multifunctional Regulators of G Protein-coupled Receptors. J Biol Chem 291, 8969-8977, doi:10.1074/jbc.R115.713313 (2016).
2. Lee, M. H. et al. The conformational signature of beta-arrestin2 predicts its trafficking and signalling functions. Nature 531, 665-668, doi:10.1038/nature17154 (2016).
3. Nuber, S. et al. beta-Arrestin biosensors reveal a rapid, receptor-dependent activation/deactivation cycle. Nature 531, 661-664, doi:10.1038/nature17198 (2016).
4. Dacres, H., Michie, M., Wang, J., Pfleger, K. D. & Trowell, S. C. Effect of enhanced Renilla luciferase and fluorescent protein variants on the Forster distance of Bioluminescence resonance energy transfer (BRET). Biochem Biophys Res Commun 425, 625-629, doi:10.1016/j.bbrc.2012.07.133 (2012).
5. Pfleger, K. D. & Eidne, K. A. Illuminating insights into protein-protein interactions using bioluminescence resonance energy transfer (BRET). Nat Methods 3, 165-174, doi:10.1038/nmeth841 (2006).
6. Lohse, M. J., Nuber, S. & Hoffmann, C. Fluorescence/bioluminescence resonance energy transfer techniques to study G-proteincoupled receptor activation and signaling. Pharmacol Rev 64, 299-336, doi:10.1124/pr.110.004309 (2012).
7. Pfleger, K. D., Seeber, R. M. & Eidne, K. A. Bioluminescence resonance energy transfer (BRET) for the real-time detection of protein-protein interactions. Nat Protoc 1, 337-345, doi:10.1038/nprot.2006.52 (2006).
8. Stoddart, L. A. et al. Application of BRET to monitor ligand binding to GPCRs. Nat Methods 12, 661-663, doi:10.1038/nmeth.3398 (2015).
9. Robers, M. B. et al. Target engagement and drug residence time can be observed in living cells with BRET. Nature Communications 6, 10091, doi:10.1038/ncomms10091 (2015).
10. Gibson, T. J., Seiler, M. & Veitia, R. A. The transience of transient overexpression. Nat Methods 10, 715-721, doi:10.1038/nmeth.2534 (2013).
11. Mahen, R. et al. Comparative assessment of fluorescent transgene methods for quantitative imaging in human cells. Mol Biol Cell 25, 3610-3618, doi:10.1091/mbc.E14-06-1091 (2014).
12. Machleidt, T. et al. NanoBRET-A Novel BRET Platform for the Analysis of Protein-Protein Interactions. ACS Chem Biol 10, 1797-1804, doi:10.1021/acschembio.5b00143 (2015).
13. Savage, E. E., Wootten, D., Christopoulos, A., Sexton, P. M. & Furness, S. G. A simple method to generate stable cell lines for the analysis of transient protein-protein interactions. Biotechniques 54, 217-221, doi:10.2144/000114013 (2013).
14. Audet, M., Lagace, M., Silversides, D. W. & Bouvier, M. Protein-protein interactions monitored in cells from transgenic mice using bioluminescence resonance energy transfer. FASEB J 24, 2829-2838, doi:10.1096/fj.09-144816 (2010).
15. Kain, S. R. & Ganguly, S. Overview of genetic reporter systems. Curr Protoc Mol Biol Chapter 9, Unit9 6, doi:10.1002/0471142727. mb0906s36 (2001).
16. Rojas-Fernandez, A. et al. Rapid generation of endogenously driven transcriptional reporters in cells through CRISPR/Cas9. Sci Rep 5, 9811, doi:10.1038/srep09811 (2015).
17. Cermak, T. et al. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Res 39, e82, doi:10.1093/nar/gkr218 (2011).
18. Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819-823, doi:10.1126/science.1231143 (2013).
19. Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat Protoc 8, 2281-2308, doi:10.1038/nprot.2013.143 (2013).
20. Hou, P. et al. Genome editing of CXCR4 by CRISPR/cas9 confers cells resistant to HIV-1 infection. Sci Rep 5, 15577, doi:10.1038/ srep15577 (2015).
21. Schumann, K. et al. Generation of knock-in primary human T cells using Cas9 ribonucleoproteins. Proc Natl Acad Sci U S A 112, 10437-10442, doi:10.1073/pnas.1512503112 (2015).
22. Mandal, P. K. et al. Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR/Cas9. Cell Stem Cell 15, 643-652, doi:10.1016/j.stem.2014.10.004 (2014).
23. Kamiyama, D. et al. Versatile protein tagging in cells with split fluorescent protein. Nat Commun 7, 11046, doi:10.1038/ ncomms11046 (2016).
24. Tanenbaum, M. E., Gilbert, L. A., Qi, L. S., Weissman, J. S. & Vale, R. D. A protein-tagging system for signal amplification in gene expression and fluorescence imaging. Cell 159, 635-646, doi:10.1016/j.cell.2014.09.039 (2014).
25. Alvarez-Curto, E. et al. Targeted Elimination of G proteins and Arrestins Defines their Specific Contributions to both Intensity and Duration of G protein-Coupled Receptor Signalling. J Biol Chem. doi:10.1074/jbc.M116.754887 (2016).
26. Ratz, M., Testa, I., Hell, S. W. & Jakobs, S. CRISPR/Cas9-mediated endogenous protein tagging for RESOLFT super-resolution microscopy of living human cells. Sci Rep 5, 9592, doi:10.1038/srep09592 (2015).
27. Lackner, D. H. et al. A generic strategy for CRISPR-Cas9-mediated gene tagging. Nat Commun 6, 10237, doi:10.1038/ncomms10237 (2015).
28. Yang, H. et al. One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell 154, 1370-1379, doi:10.1016/j.cell.2013.08.022 (2013).
29. Molinari, P., Casella, I. & Costa, T. Functional complementation of high-efficiency resonance energy transfer: a new tool for the study of protein binding interactions in living cells. Biochem J 409, 251-261, doi:10.1042/bj20070803 (2008).
30. Hall, M. P. et al. Engineered luciferase reporter from a deep sea shrimp utilizing a novel imidazopyrazinone substrate. ACS Chem Biol 7, 1848-1857, doi:10.1021/cb3002478 (2012).
31. Goyet, E., Bouquier, N., Ollendorff, V. & Perroy, J. Fast and high resolution single-cell BRET imaging. Sci Rep 6, 28231, doi:10.1038/ srep28231 (2016).
32. Zou, Y. R., Kottmann, A. H., Kuroda, M., Taniuchi, I. & Littman, D. R. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393, 595-599, doi:10.1038/31269 (1998).
33. Zhao, H. et al. CXCR4 over-expression and survival in cancer: a system review and meta-analysis. Oncotarget 6, 5022-5040, doi:10.18632/oncotarget.3217 (2015).
34. Hernandez, P. A. et al. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat Genet 34, 70-74, doi:10.1038/ng1149 (2003).
35. Feng, Y., Broder, C. C., Kennedy, P. E. & Berger, E. A. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272, 872-877, doi:10.1126/science.272.5263.872 (1996).
36. Busillo, J. M. et al. Site-specific phosphorylation of CXCR4 is dynamically regulated by multiple kinases and results in differential modulation of CXCR4 signaling. J Biol Chem 285, 7805-7817, doi:10.1074/jbc.M109.091173 (2010).
37. Pikaart, M. I., Recillas-Targa, F. & Felsenfeld, G. Loss of transcriptional activity of a transgene is accompanied by DNA methylation and histone deacetylation and is prevented by insulators. Genes & Development 12, 2852-2862, doi:10.1101/gad.12.18.2852 (1998).
38. Moriuchi, M., Moriuchi, H., Margolis, D. M. & Fauci, A. S. USF/c-Myc enhances, while Yin-Yang 1 suppresses, the promoter activity of CXCR4, a coreceptor for HIV-1 entry. J Immunol 162, 5986-5992 (1999).
39. Bassoni, D. L., Raab, W. J., Achacoso, P. L., Loh, C. Y. & Wehrman, T. S. Measurements of beta-arrestin recruitment to activated seven transmembrane receptors using enzyme complementation. Methods Mol Biol 897, 181-203, doi:10.1007/978-1-61779-909-9-9 (2012).
40. Shenoy, S. K. & Lefkowitz, R. J. Trafficking patterns of beta-arrestin and G protein-coupled receptors determined by the kinetics of beta-arrestin deubiquitination. J Biol Chem 278, 14498-14506, doi:10.1074/jbc.M209626200 (2003).
41. Lan, T. H., Kuravi, S. & Lambert, N. A. Internalization dissociates beta2-adrenergic receptors. PLoS One 6, e17361, doi:10.1371/ journal.pone.0017361 (2011).
42. Tiulpakov, A. et al. Mutations of Vasopressin Receptor 2 Including Novel L312S Have Differential Effects on Trafficking. Mol Endocrinol 30, 889-904, doi:10.1210/me.2016-1002 (2016).
43. Wysoczynski, M. et al. Incorporation of CXCR4 into membrane lipid rafts primes homing-related responses of hematopoietic stem/ progenitor cells to an SDF-1 gradient. Blood 105, 40-48, doi:10.1182/blood-2004-04-1430 (2005).
44. Busillo, J. M. & Benovic, J. L. Regulation of CXCR4 signaling. Biochim Biophys Acta 1768, 952-963, doi:10.1016/j. bbamem.2006.11.002 (2007).
45. Beletkaia, E. et al. CXCR4 signaling is controlled by immobilization at the plasma membrane. Biochim Biophys Acta 1863, 607-616, doi:10.1016/j.bbamcr.2015.12.020 (2016).
46. See, H. B., Seeber, R. M., Kocan, M., Eidne, K. A. & Pfleger, K. D. Application of G protein-coupled receptor-heteromer identification technology to monitor beta-arrestin recruitment to G protein-coupled receptor heteromers. Assay Drug Dev Technol 9, 21-30, doi:10.1089/adt.2010.0336 (2011).
47. LaRocca, T. J. et al. beta2-Adrenergic receptor signaling in the cardiac myocyte is modulated by interactions with CXCR4. J Cardiovasc Pharmacol 56, 548-559, doi:10.1097/FJC.0b013e3181f713fe (2010).
48. Levoye, A., Balabanian, K., Baleux, F., Bachelerie, F. & Lagane, B. CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling. Blood 113, 6085-6093, doi:10.1182/blood-2008-12-196618 (2009).
49. Decaillot, F. M. et al. CXCR7/CXCR4 heterodimer constitutively recruits beta-arrestin to enhance cell migration. J Biol Chem 286, 32188-32197, doi:10.1074/jbc.M111.277038 (2011).
50. Iyama, T. & Wilson, D. M. 3rd DNA repair mechanisms in dividing and non-dividing cells. DNA Repair (Amst) 12, 620-636, doi:10.1016/j.dnarep.2013.04.015 (2013).
51. Chan, F., Hauswirth, W. W., Wensel, T. G. & Wilson, J. H. Efficient mutagenesis of the rhodopsin gene in rod photoreceptor neurons in mice. Nucleic Acids Res 39, 5955-5966, doi:10.1093/nar/gkr196 (2011).
52. Merkle, F. T. et al. Efficient CRISPR-Cas9-mediated generation of knockin human pluripotent stem cells lacking undesired mutations at the targeted locus. Cell Rep 11, 875-883, doi:10.1016/j.celrep.2015.04.007 (2015).
53. Zetsche, B. et al. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell 163, 759-771, doi:10.1016/j. cell.2015.09.038 (2015).
54. Zhao, J., Nelson, T. J., Vu, Q., Truong, T. & Stains, C. I. Self-Assembling NanoLuc Luciferase Fragments as Probes for Protein Aggregation in Living Cells. ACS Chem Biol 11, 132-138, doi:10.1021/acschembio.5b00758 (2016).
55. Irannejad, R. et al. Conformational biosensors reveal GPCR signalling from endosomes. Nature 495, 534-538, doi:10.1038/ nature12000 (2013).
56. Jensen, D. D. et al. The bile acid receptor TGR5 does not interact with beta-arrestins or traffic to endosomes but transmits sustained signals from plasma membrane rafts. J Biol Chem 288, 22942-22960, doi:10.1074/jbc.M113.455774 (2013).
57. Lan, T. H., Liu, Q., Li, C., Wu, G. & Lambert, N. A. Sensitive and high resolution localization and tracking of membrane proteins in live cells with BRET. Traffic 13, 1450-1456, doi:10.1111/j.1600-0854.2012.01401.x (2012).
58. Namkung, Y. et al. Monitoring G protein-coupled receptor and [beta]-arrestin trafficking in live cells using enhanced bystander BRET. Nat Commun 7, doi:10.1038/ncomms12178 (2016).
59. Esseltine, J. L., Dale, L. B. & Ferguson, S. S. Rab GTPases bind at a common site within the angiotensin II type I receptor carboxylterminal tail: evidence that Rab4 regulates receptor phosphorylation, desensitization, and resensitization. Mol Pharmacol 79, 175-184, doi:10.1124/mol.110.068379 (2011).
60. Esseltine, J. L. & Ferguson, S. S. Regulation of G protein-coupled receptor trafficking and signaling by Rab GTPases. Small GTPases 4, 132-135, doi:10.4161/sgtp.24304 (2013).
61. Dale, L. B., Seachrist, J. L., Babwah, A. V. & Ferguson, S. S. Regulation of angiotensin II type 1A receptor intracellular retention, degradation, and recycling by Rab5, Rab7, and Rab11 GTPases. J Biol Chem 279, 13110-13118, doi:10.1074/jbc.M313333200 (2004).
62. Seachrist, J. L., Anborgh, P. H. & Ferguson, S. S. beta 2-adrenergic receptor internalization, endosomal sorting, and plasma membrane recycling are regulated by rab GTPases. J Biol Chem 275, 27221-27228, doi:10.1074/jbc.M003657200 (2000).
63. Breton, B. et al. Multiplexing of multicolor bioluminescence resonance energy transfer. Biophys J 99, 4037-4046, doi:10.1016/j. bpj.2010.10.025 (2010).
64. Hsu, P. D. et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol 31, 827-832, doi:10.1038/nbt.2647 (2013).
65. Kent, W. J. et al. The human genome browser at UCSC. Genome Res 12, 996-1006, doi:10.1101/gr.229102 (2002)
66. Zhang, J. H., Chung, T. D. & Oldenburg, K. R. A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J Biomol Screen 4, 67-73 (1999).
67. Kocan, M., See, H. B., Seeber, R. M., Eidne, K. A. & Pfleger, K. D. Demonstration of improvements to the bioluminescence resonance energy transfer (BRET) technology for the monitoring of G protein-coupled receptors in live cells. J Biomol Screen 13, 888-898, doi:10.1177/1087057108324032 (2008).
68. Porrello, E. R. et al. Heteromerization of angiotensin receptors changes trafficking and arrestin recruitment profiles. Cell Signal 23, 1767-1776, doi:10.1016/j.cellsig.2011.06.011 (2011).
69. Kocan, M. et al. Agonist-independent interactions between beta-arrestins and mutant vasopressin type II receptors associated with nephrogenic syndrome of inappropriate antidiuresis. Mol Endocrinol 23, 559-571, doi:10.1210/me.2008-0321 (2009).